Your SlideShare is downloading. ×
GENERAL CONCEPTS Immune system distinguishes between self ...
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

GENERAL CONCEPTS Immune system distinguishes between self ...


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. GENERAL CONCEPTS • Immune system distinguishes between self (auto) and non-self (foreign) antigens • V genes encode TCR’s and BCR’s with anti-self reactivity • Autoreactive T and B cells are produced • If mature autoreactive T and B cells are activated, autoimmune disease may develop • Self-tolerance mechanisms eliminate or prevent autoreactive cells from responding
  • 2. TOLERANCE • Antigen-specific unresponsiveness • Acquired characteristic - Somatic process • Central tolerance occurs in primary lymphoid organs during lymphocyte maturation • Peripheral tolerance occurs in secondary lymphoid organs involving mature cells • Time dependent • Antigen concentration dependent Low vs. High Zone Tolerance
  • 3. T cells are easier to tolerize than B cells. If helper T cell is tolerant, B cell will not respond. Without T cell help, B cell undergoes apoptosis.
  • 4. Mechanisms of T Cell Tolerance • Antigen Sequestration Immunological Privileged Site • Deletion • Suppression • Anergy • Immunological Ignorance • Receptor Editing NOT important
  • 5. Fetus is an allograft, but no immune response occurs.
  • 6. Immune Privileged Sites • Lack of immune responses • Examples: fetus, brain, anterior chamber of eye • Lymphocytes have access and self antigens exit • Lack of conventional lymphatics • Rich in inhibitory molecules
  • 7. DELETION • Cells killed • Activation-induced cell death Peripheral tolerance mechanism Cells die during an immune response Mediated by Fas pathway • Main mechanism of central tolerance: Negative selection in thymus
  • 8. Activation- Induced Cell Death Apoptosis is mediated by Fas pathway. Defect causes fatal multi-organ autoimmune disease
  • 9. Medulla
  • 10. Implications for bone marrow transplantation patients
  • 11. Avidity Model vs. No Positive Selection Cell Death Differential Signaling Model No Signal DP T Cell Stromal Weak or Partial Cell Positive Selection TCR MHC + Signal Antigen Strong or Full Signal Negative Selection Cell Death
  • 12. SUPPRESSION • Hallmark Feature: Adoptively transferred with T cells • Regulatory CD4+ T cells secrete inhibitory cytokines especially TGF- • Release of soluble cytokine receptors • Immune Deviation - Change TH1 to TH2 response or reverse
  • 13. IL-4, IL-10, TGF- FoxP3 Mutations in FoxP3 cause fatal multi-organ autoimmune disease in humans
  • 14. Soluble cytokine receptors neutralize cytokines
  • 15. Immune Deviation = Cytokine Deviation Subverts main pathological mechanism causing the autoimmune disease
  • 16. ANERGY • Peripheral tolerance mechanism • Cells functionally inactivated and not capable of responding to antigen • Low or no interleukin-2 secretion is one main effect • Cells remain alive • Long-term effect • Caused by improper primary signal or lack of costimulatory signal
  • 17. Peptide analog acts as partial agonist delivering negative signa
  • 18. Not suppression
  • 19. Second Primary signal = signal co-stimulatory
  • 20. Naive T cells interact with professional antigen-presenting cells for a primary response Other cell types lack MHC class II and co-stimulatory molecules and cause anergy.
  • 21. Lack of signal via CD28 renders T cells unable to produce IL-2
  • 22. B-7’s CD28
  • 23. Particular CTLA-4 allele increases risk for certain autoimmune diseases in humans
  • 24. SUMMARY OF ANERGY • Analog peptides act as partial agonist and generate negative signal • Disruption of CD4 or CD8 co-receptors impairs primary signal • Lack of costimulatory signal from non- professional antigen-presenting cells No CD28 signal renders T cells unable to produce IL-2 • CTLA-4 generates negative signal Blocks IL-2 production
  • 25. IMMUNOLOGICAL IGNORANCE • Peripheral tolerance mechanism • Cells are alive and capable of responding • Cells “ignorant” of antigen and do not respond • Occurs if TCR has low affinity and/or antigen concentration is low • Increase in antigen concentration may lead to a response
  • 26. Example of Immunological Ignorance
  • 27. IMMUNOLOGICAL IGNORANCE • One Mechanism involves Antigen Processing • Peptide of intact self protein antigen is not made by antigen-presenting cells during antigen processing • T cells are not tolerant to that self peptide • Example: 1. Administer intact mouse cytochrome c, and nothing happens. 2. Administer peptide of mouse cytochrome c, and autoimmune disease develops.
  • 28. Promising Immunotherapies • Peptide agonists to treat allergies • Anti-B7 antibodies to prevent graft rejection • Soluble CTLA-4 to treat autoimmune diseases and prevent graft rejection • Anti-CD4 antibody to prevent graft rejection and treat multiple sclerosis • Th1 cytokines to treat IgE-mediated allergies • Soluble TNF receptor (Enbrel) to treat rheumatoid arthritis, ankylosing spondylitis and severe psoriasis - FDA approved
  • 29. Promising Immunotherapies - Continued • Anti-CTLA-4 antibody to boost T cell responses to melanoma and prostate cancer • Tumors transfected with B7 genes to induce T cell responses to tumors One published clinical trial with melanoma and glioblastoma patients
  • 30. T